Human, canine and murine BRCA1 genes: Sequence comparison among species

Human Molecular Genetics

Volumn 5, Issue 9, 1996, Pages 1289-1298

  Szabo, Csilla I ^a   Wagner, Lori A ^b   Francisco, Leigh V ^b   Roach, Jared C ^c   Argonza, Rhoda ^a   King, Mary Claire ^a   Ostrander, Elaine A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GENETICS; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; DNA POLYMORPHISM; DOG; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DOGS; GENES, BRCA1; HUMANS; MICE; MOLECULAR SEQUENCE DATA;

ANIMALIA; CANIS FAMILIARIS; MURINAE;

EID: 0029814509     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.9.1289     Document Type: Article

References (95)

1. Feuer, E, Wun, L, Boring, C, Flanders, W, Timmel, M, and Tong, T (1993). The lifetime risk of developing breast cancer. J. Natl Cancer Inst. 85, 892-897.
2. Newmar, B, Austin, MA, Lee, M, and King, M-C (1988). Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. Proc. Natl Acad. Sci. USA 85, 33044-3048.
3. Claus, EB, Risch, N, and Thompson, WD (1991). Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48, 232-242.
4. Hall, JM, Lee, MK, Newman, B, Morrow, JE, Anderson, LA, Huey, B, and King, M-C (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689.
5. Miki, Y, Swensen, J, Shattuck-Eidens, D, Futreal, PA, Harshman, K, Tavtigian, S, Liu, Q, Cochran, C, Bennett, LM, Ding, W, Bell, R, Rosenthal, J, Hussey, C, Tran, T, McClure, M, Frye, C, Mattier, T, Phelps, R, Haugen-Strano, A, Katcher, H, Yakumo, K, Gholami, Z, Shaffer, D, Stone, S, Bayer, S, Wray, C, Bogden, R, Dayananth, P, Ward, J, Tonin, P, Narod, S, Bristow, PK, Norris, FH, Helvering, L, Morrison, P, Rosteck, P, Lai, M, Barrett, JC, Lewis, C, Neuhausen, S, Cannon-Albright, L, Goldgar, D, Wiseman, R, Kamb, A, and Skolnick, MH (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
6. Wooster, R, Neuhausen, SL, Mangion, J, Quirk, Y, Ford, D, Collins, N, Nguyen, K, Seal, S, Tran, T, Averill, D, Fields, P, Marshall, G, Narod, S, Lenoir, G, Lynch, H, Feunteun, Devilee, P, Cornelisse, CJ, Menko, FH, Daly, PA, and Ormi (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090.
7. Wooster, R, Bignell, G, Lancaster, J, Swift, S, Seal, S, Mangion, J, Collins, N, Gregory, S, Gumbs, C, Micklem, G, Barfoot, R, Hamoudi, R, Patel, S, Rice, C, Biggs, P, Hashim, Y, Smith, A, Connor, F, Arason, A, Gudmundsson, J, Ficenec, D, Kelsell, D, Ford, D, Tonin, P, Bishop, D, Spurr, N, Ponder, B, Eeles, R, Peto, J, Devilee, P, Cornelisse, C, Lynch, H, Narod, S, Lenoir, G, Egilsson, V, Barkadottir, R, Easton, D, Bentley, D, Futreal, A, Ashworth, A, and Stratton, M (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.
8. Easton, DF, Bishop, DT, Ford, D, Crockford, GP, and The Breast Cancer Linkage Consortium (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52, 678-701.
9. Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE, and The Breast Cancer Linkage Consortium (1994). Risks of cancer in BRCA1-mutation carriers. Lancet 343, 692-695.
10. Futreal, PA, Liu, Q, Shattuck-Eidens, D, Cochran, C, Harshman, K, Tavtigian, S, Bennett, LM, Haugen-Strano, A, Swensen, J, Miki, Y, Eddington, K, McClure, M, Frye, C, Weaver-Feldhaus, J, Ding, W, Gholami, Z, Soderkvist, P, Terry, L, Jhanwar, S, Berchuck, A, Iglehart, JD, Marks, J, Ballinger, DG, Barrett, JC, Skolnick, MH, Kamb, A, and Wiseman, R (1994). BRCA1 mutations in primary breast and ovarian carinomas. Science 266, 120-122.
11. Simard, J, Tonin, P, Durocher, F, Morgan, K, Rommens, J, Gingras, S, Samson, C, Leblanc, J-F, Belanger, C, Dion, F, Liu, Q, Skolnick, M, Goldar, D, Shattuck-Eidens, D, Labrie, F, and Narod, SA (1994). Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet. 8, 392-398.
12. Castilla, LH, Couch, FJ, Erdos, MR, Hoskins, KF, Calzone, K, Garaber, J, Boyd, J, Lubin, MB, Deshano, ML, Brody, LC, Collins, FS, and Weber, BL (1994). Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 8, 387-391.
13. Friedman, LS, Ostermeyer, EA, Szabo, CI, Dowd, P, Lynch, ED, Rowell, SE, and King, M-C (1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8, 399-404.
14. Shattuck-Eidens, D, McClure, M, Simard, J, Labrie, F, Narod, S, Couch, F, Weber, B, Castilla, L, Brody, L, Friedman, L, Ostermeyer, E, Szabo, C, King, M-C, Jhanwar, S, Offit, K, Norton, L, Gilewski, T, Lubin, M, Osborne, M, Black, D, Boyd, M, Steel, M, Ingles, S, Haile, R, Lindblom, A, Borg, Å, Bishop, DT, Solomon, E, Radice, P, Spatti, G, Gayther, S, Ponder, B, Warren, W, Stratton, M, Liu, Q, Fujimura, F, Lewis, C, Skolnick, MH, and Goldgar, DE (1995). A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273, 535-541.
15. Merajver, SD, Pham, TM, Caduff, RF, Chen, M, Poy, EL, Cooney, KA, Weber, BL, Collins, FS, Johnston, C, and Frank, TS (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439-443.
16. Hosking, L, Trowsdale, J, Nicolai, H, Solomon, E, Foulkes, W, Stamp, G, Signer, E, and Jeffreys, A (1995). A somatic BRCA1 mutation in an ovarian tumor. Nature Genet. 9, 343-344.
17. Hogervorst, FBL, Cornelis, RS, Bout, M, van Vliet, M, OOsterwijk, JC, Olmer, R, Bakker, B, Klijn, JGM, Vasen, HFA, Meijers-Heijboer, H, Menko, FH, Cornelisse, CJ, den Dunnen, JT, Devilee, P, and van Ommen, G-JB (1995). Rapid detection of BRCA1 mutations by the protein truncation test Nature Genet. 10, 208-212.
18. Struewing, JP, Brody, LC, Erdos, MR, Kase, RG, Giambarresi, TR, Smith, SA, Collins, FS, and Tucker, MA (1995). Detection of eight BRCAI mutations in ten breast/ovarian cancer families, including one family with male breast cancer. Am. J. Hum. Genet. 57, 1-7.
19. Takahashi, H, Behbakht, K, McGovern, PE, Chiu, H-C, Couch, FJ, Weber, BL, Friedman, LS, King, M-C, Furusato, M, LiVolsi, VA, Menzin, AW, Liu, PC, Benjamin, I, Morgan, MA, King, SA, B.A., R, Cardonick, A, Mikuta, JJ, Rubin, SC, and Boyd, J (1995). Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55, 2998-3002.
20. Szabo, CI and King, M-C (1995). Inherited breast and ovarian cancer. Hum. Mol. Genet. 4, 1811-1817.
21. Friedman, LS, Szabo, CI, Ostermeyer, EA, Dowd, P, Butler, L, Park, T, Lee, MK, Goode, EL, Rowell, SE, and King, M-C (1995). Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am. J. Hum. Genet. (in press).
22. Gayther, S, Warren, W, Mazoyer, S, Russell, P, Harrington, P, Chiano, M, Seal, S, Hamoudi, R, van Rensburg, E, Dunning, A, Love, R, Evans, G, Easton, D, Clayton, D, Stratton, M, and Ponder, B (1995). Germline mutations of the BRCAI gene in breast and ovarian cancer provide evidence for a genotype-phenotype correlation. Nature Genet. 11, 428-433.
23. Langston, A, Malone, K, Thompson, J, Daling, J, and Ostrander, E (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med 334, 137-142.
24. FitzGerald, M, MacDonald, D, Krainer, M, Hoover, I, O'Neil, E, Unsal, H, Silva-Arrieto, B, Finkelstein, D, Beer-Romero, P, Englert, C, Soroi, D, Smith, B, Younger, J, Garber, J, Duda, R, Mayzel, K, Isselbacher, K, Friend, S, and Haber, D (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer N. Engl. J. Med. 334, 143-149.
25. Serova, O, Montagna, M, Torchard, D, Narod, SA, Tonin, P, Sulla, B, Lynch, HT, Feunteun, J, and Lenoir, GM (1996). A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet. 58, 42-51.
26. Johannsson, O, Ostermeyer, EA, Håkansson, S, Friedman, LS, Jonahsson, U, Sellberg, G, Brøndum-Nielsen, K, Sele, V, Olsson, H, King, M-C, and Borg, Å (1996), Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am. J. Hum. Genet. 58, 441-450.
27. Gayther, SA, Harrington, P, Russell, P, Kharkevich, G, Garkavtseva, RF, Ponder, BAJ, and the UKCCCR Familial Ovarian Cancer Study Group (1996). Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am. J. Hum. Genet. 58, 451-456.
28. Durocher, F, Shattuck-Eidens, D, McClure, M, Labrie, F, Skolnick, MH, Goldgar, DE, and Simard, J (1996). Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum. Mol. Genet. 5, 835-842.
29. Tavtígian, S, Simard, J, Rommens, J, Couch, F, Shattuck-Eidens, D, Neuhausen, S, Merajver, S, Thorlacius, S, Offit, K, Stoppa-Lyonnet, D, Belanger, C, Bell, R, Berry, S, Bogden, R, Chen, Q, Davis, T, Dumont, M, Frye, C, Hattier, T, Jammulapati, S, Janecki, T, Jiang, P, Kehrer, R, Leblanc, J-F, Mitchell, J, McArthur-Morrison, J, Nguyen, K, Peng, Y, Samson, C, Schroeder, M, Snyder, S, Steele, L, Stringfellow, M, Stroup, C, Swedlund, B, Swensen, J, Teng, D, Thomas, A, Tran, T, Tranchant, M, Weaver-Feldhaus, J, Wong, A, Shizuya, H, Eyfjord, J, Cannon-Albright, L, Labrie, F, Skolnick, M, Weber, B, Kamb, A, and Goldgar, D (1995). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet. 12, 333-7.
30. Thoriacius, S, Olafsdottir, G, Tryggvadottir, L, Neuhausen, S, Jonasson, JG, Tavitgian, SV, Tulinius, H, Ögmundsdottir, HM, and Eyfjörd, JE (1996). A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet. 13, 117-119.
31. Phelan, CM, Lancaster, JM, Tonin, P, Gumbs, C, Cochran, C, Carter, R, Ghadirian, P, Perret, C, Moslehi, R, Dion, F, Faucher, M-C, Kole, K, Karimi, S, Foulkes, W, Lounis, H, Warner, E, Goss, P, Anderson, D, Larsson, C, Narod, SA, and Futreal, PA (1996). Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet. 13, 120-122.
32. Couch, FJ, Farid, LM, DeShano, ML, Tavitgian, SV, Calzone, K, Campeau, L, Peng, Y, Bogden, B, Chen, Q, Neuhausen, S, Shattuck-Eidens, D, Godwin, AK, Daly, M, Radford, DM, Sedlacek, S, Rommens, J, Simard, J, Garber, J, Merajver, S, and Weber, BL (1996). BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet. 13, 123-125.
33. Neuhausen, S, Gilewski, T, Norton, L, Tran, T, McGuire, P, Swensen, J, Hampel, H, Borgen, P, Brown, K, Skolnick, M, Shattuck-Eidens, D, Jhanwar, S, Goldgar, D, and Offit, K (1996). Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer Nature Genet. 13, 126-128.
34. Smith, SA, Easton, DF, Evands, DGR, and Ponder, BAJ (1992). Allele losses in the region 17q12-q21 in familial breast and ovarian cancer non-randomly involve the wild-type chromosome. Nature Genet. 2, 128-131.
35. Neuhausen, SL and Marshall, CJ (1994). Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54, 6069-6072.
36. Friedman, LS, Ostermeyer, EA, Lynch, ED, Szabo, CI, Anderson, LA, Dowd, P, Lee, MK, Rowell, SE, Boyd, J, and King, M-C (1994). The search for BRCA1. Cancer Res. 54, 6374-6382.
37. Gudmundsson, J, Johannesdottir, G, Bergthorsson, J, Arason, A, Ingvarsson, S, Egilsson, V, and Barkardottir, R (1995). Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 55, 4830-4832.
38. Saito, H, Inazawa, J, Saito, S, Kasumi, F, Koi, S, Sagae, S, Kudo, R, Saito, J, Noda, K, and Nakamura, Y (1993). Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res. 53, 3382-3385.
39. Cropp, CS, Champeme, MH, Lidereau, R, and Callahan, R (1993). Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res. 53, 5617-5619.
40. Russell, SE, Hickey, GI, Lowry, WS, White, P, and Atkinson, RJ (1990). Allele loss from chromosome 17 in ovarian cancer Oncogene 5, 1581-1583.
41. Cliby, W, Ritland, S, Hartmann, L, Dodson, M, Halling, KC, Keeney, G, Podratz, KC, and Jenkins, RB (1993). Human epithelial ovarian cancer allelotype. Cancer Res. 53, 2393-2398.
42. Yang-Feng, TL, Han, H, Chen, KC, Li, SB, Claus, EB, Carcangiu, ML, Chambers, SK, Chambers, JT, and Schwartz, PE (1993). Allelic loss in ovarian cancer Int. J. Cancer. 54, 546-551.
43. Kerangueven, F, Allione, F, Noguchi, T, Ad'elaide, J, Sobol, H, Jacquemier, J, and Birnbaum, D (1995). Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer. 13, 291-294.
44. Cleton-Jansen, A, Collins, N, Lakhani, S, Weissenbach, J, Devilee, P, Cornelisse, C, and Stratton, M (1995). Loss of heterozygosity in sporadic breast tumors at the BRCA2 locus on chromosome 13q12-q13. Br. J. Cancer 72, 1241-1244.
45. Thompson, ME, Jensen, RA, Obermiller, PS, Page, DS, and Holt, JT (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Gener. 9, 444-450.
46. Lovering, R, Hanson, IM, Borden, KL, Martin, S, O'Reilly, NJ, Evan, GI, Rahman, D, Pappin, DJ, Trowsdale, J, and Freemont, PS (1993). Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl Acad. Sci. USA. 90, 2112-2116.
47. Holt, J, Thompson, M, Szabo, C, Robinson-Benion, C, Arteage, C, King, M-C, and Jensen, R (1996). Growth retardation and tumor inhibition by BRCA1. Nature Genet. 12, 298-302.
48. Zakut, HR, Bienz, TB, Givol, D, and Oren, M (1985). Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J. 4, 1251-1255.
49. Doetschman, T, Maeda, N, and Smithies, O (1988). Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA. 85, 8583-8587.
50. Capecchi, MR (1989). Altering the genome by homologous recombination. Science 244, 1288-1292.
51. Sawai, S, Shimono, A, Hanaoka, K, and Kondoh, H (1991). Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol. 3, 861-869.
52. Moens, CB, Auerbach, AB, Conlon, RA, Joyner, AL, and Rossant, J (1992). A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 6, 691-704.
53. Soriano, P, Montgomery, C, Geske, R, and Bradley, A (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
54. Donehower, LA, Harvey, M, Slagle, BL, McArthur, MJ, Montgomery, CJ, Butel, JS, and Bradley, A (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
55. Jacks, T, Remington, L, Williams, BO, Schmitt, EM, Halachmi, S, Bronson, RT, and Weinberg, RA (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
56. Hu, N, Gutsmann, A, Herbert, DC, Bradley, A, Lee, WH, and Lee, EY (1994). Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-1027.
57. Williams, B, Remington, L, Albert, D, Mukai, S, Bronson, R, and Jacks, T (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet. 7, 480-484.
58. Dietrich, W, Lander, E, Smith, J, Moser, A, Gould, K, Luongo, C, Borenstein, N, and Dove, W (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
59. Owen, LN (1979). A comparative study of canine and human breast cancer. Invest. Cell. Pathol. 2, 257-275.
60. Brodey, RS, Goldschmidt, MH, and Roszel, JR (1983). Canine mammary gland neoplasms. J. Am. Animal Hos. Assn. 19, 61-90.
61. MacEwen, EG (1990). Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer Metastasis Rvw 9, 125-136.
62. Dorn, CR, Taylor, DO, Schneider, R, Hibbard, HH, and Klauber, MR (1968). Survey of animal neoplasms in Alameda and Contra Costa Counties. California II. Cancer morbidity in dogs and cats from Alameda County. J. Natl. Cancer Inst. 40, 307-318.
63. Strandberg, JD (1974). Animal model: Canine mammary neoplasia. Am. J. Path. 75, 225-228.
64. Cohen, D, Reif, J, Brody, RS, and Keiser H (1974). Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res. 34, 2859-2868.
65. Russo, J, Gusterson, B, Rogers, A, Russo, I, Wellings, S, and van Zwieten, M (1990). Biology of disease: Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62, 244-278.
66. Fidler, I and Brodey, R (1967). A necropsy study of canine malignant mammary neoplasms. J. Am. Vet. Assn. 151, 710-715.
67. Fidler, I, Abt, D, and Brodey, R (1967). The biological behavior of canine mammary neoplasms. J. Am. Vet. Assn. 151, 1311-1318.
68. MacEwen, EG, Patnaik, AK, Harvey, HJ, and Panko, WB (1982). Estrogen receptors in canine mammary tumors. Cancer Res. 42, 2255-2259.
69. Martin, P, Cotard, M, and Mialot, J (1984). Animal models for hormone-dependent human breast cancer. Cancer Chemother. Pharmacol. 12, 13-17.
70. Schneider, R, Dorn, C, and Taylor, D (1969). Factors influencing mammary cancer development and post surgical survival. J. Natl. Cancer Inst. 43, 1249-1261.
71. Taylor, G, Shabesyari, L, Williams, J, Mays, C, Angus, W, and McFarland, S (1976). Mammary neoplasia in a closed beagle colony. Cancer Res. 36, 2740-2743.
72. Moulton, J, Rosenblatt, L, and Goldman, M (1986). Mammary tumors in a colony of beagle dogs. Vet. Pathol. 23, 741-749.
73. Bennett, L, Haugen-Strano, A, Cochran, C, Brownlee, H, Fiedorek, F, and Wiseman, R (1995). Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics 29, 576-581.
74. Abel, K, Xu, J, Yin, G-Y, Lyons, R, Meisler, M, and Weber, B (1995). Mouse BRCA1: localization, sequence analysis and identification of evolutionarily conserved domains. Hum Mol. Genet. 4, 2265-2273.
75. Sharan, S, Wims, M, and Bradley, A (1995). Murine BRCA1: sequence and significance for human missense mutations. Hum. Mol. Genet. 4, 2275-2278.
76. Lane, T, Deng, C, Elson, A, Lyu, M, Kozak, C, and Leder, P (1995). Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes & Dev. 9, 2712-2722.
77. Smith, T, Lee, M, Szabo, C, Jerome, N, McEuen, M, Taylor, M, Hood, L, and King, M-C (in preparation).
78. Avers, C, Process and Pattern in Evolution, ed. 1989, NY: Oxford University Press.
79. Kalderon, D, Roberts, B, Richardson, W, and Smith, A (1984). A short amino acid sequence able to specify nuclear localization. Cell 39, 499-509.
80. Durocher, F, Shattuck-Eidens, D, Skolnick, MH, Goldgar, DE, and Simard, J (1995). Detection of polymorphisms and missense mutations in BRCA1 gene. Am. J. Hum. Genet. suppl. 57, A63, Abstract #331.
81. Inoue, R, Fukutomi, T, Ushijima, T, Matsumoto, Y, Sugimura, T, and Nagao, M (1995). Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res. 55, 3521-3524.
82. Newman, B and King, M-C (unpublished data).
83. Jensen, R, Thompson, M, Jetton, T, Szabo, C, van der Meer, R, Helou, B, Tronick, S, Page, D, King, M-C, and Holt, J (1996). BRCA1 is secreted and exhibits properties of a granin. Nature Genet. 12, 303-308.
84. Huttner, W, Gerdes, H, and Ross, P (1991). The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16, 27-30.
85. Baxevanis, A and Vinson, C (1993). Interactions of coiled coils in transcription factors: where is the specificity? Curr. Opinion Genet. Dev. 3, 278-285.
86. O'Shea, E, Klemm, J, Kim, P, and Alber, T (1991). X-ray structure of the GCN4 leucine zipper, a two stranded, parallel coiled coil. Science 254, 539-254.
87. Freemont, P (1993). The RING finger: A novel protein sequence motif related to the zinc fingen Ann. NY Acad. Sci. 684, 174-192.
88. Wu, T, Jih, M, Wang, L, and Wan, Y (1994). Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. Mol. Reprod. Devel. 38, 9-15.
89. Delaney, S, Koopman, P, Lovelock, P, and Wainwright, B (1994). Alternative splicing of the first nucleotide binding fold of CFTR in mouse testes is associated with specific stages of spermatogenesis. Genomics 20, 517-518.
90. Hall, C, Sin, W, Teo, M, Michael, G, Smith, P, Dong, J, Lim, H, Manser, E, Spurr, N, Jones, T, et al. (1993). Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternative splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes. Mol. Cell. Biol. 13, 4986-4998.
91. Goodson, M, Park-Sarge, O, and Sarge, K (1995). Tissue-dependent expression of heat shock factor 2 isoforms with distinct transcriptional activities. Mol. Cell. Biol. 15, 5288-5293.
92. n markers for genetic mapping in dog. Genomics 16, 207-213.
93. Frohman, M, Dush, M, and Martin, G (1988). Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl Acad. Sci. USA. 85, 8998-9002.
94. Elledge, S, Mulligan, J, Ramer, S, Spottswood, M, and Davis, R (1991). λYES: A multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations. Proc. Natl Acad. Sci. USA 88, 1731-1735.
95. Henikoff, S and Henikoff JG (1992). Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 89, 10915-10919.